X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3) 3
index medicus (3) 3
oncology (3) 3
adult (2) 2
cancer (2) 2
chemotherapy (2) 2
female (2) 2
kaplan-meier estimate (2) 2
male (2) 2
middle aged (2) 2
physics (2) 2
proportional hazards models (2) 2
acute myelogenous leukemia (1) 1
adaptor proteins, vesicular transport - antagonists & inhibitors (1) 1
adaptor proteins, vesicular transport - genetics (1) 1
adaptor proteins, vesicular transport - metabolism (1) 1
aerospace engineering (1) 1
age factors (1) 1
aged (1) 1
aged, 80 and over (1) 1
aml (1) 1
amsu-b (1) 1
analysis (1) 1
antibiotics, antineoplastic - therapeutic use (1) 1
antibodies (1) 1
antigens (1) 1
antimetabolites, antineoplastic - therapeutic use (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
argonaute (1) 1
atg14 (1) 1
au nanoparticles (1) 1
autophagy (1) 1
autophagy-related proteins - antagonists & inhibitors (1) 1
autophagy-related proteins - genetics (1) 1
autophagy-related proteins - metabolism (1) 1
biomarkers (1) 1
biomarkers, tumor (1) 1
blotting, western (1) 1
bone marrow (1) 1
bone-marrow (1) 1
breast-carcinoma (1) 1
c-met (1) 1
caga (1) 1
cancer-cells (1) 1
carcinogenesis (1) 1
cell biology (1) 1
cell differentiation (1) 1
cells (1) 1
cells, cultured (1) 1
chemistry (1) 1
chemotherapy, adjuvant (1) 1
classification (1) 1
clinical trials (1) 1
combination (1) 1
comparative analysis (1) 1
core-shell structure (1) 1
cytarabine (1) 1
cytarabine - therapeutic use (1) 1
daunorubicin - therapeutic use (1) 1
density (1) 1
development and progression (1) 1
disease progression (1) 1
disease-free survival (1) 1
double-blind method (1) 1
earth sciences (1) 1
elderly-patients (1) 1
engineering and technology (1) 1
expression (1) 1
fabrication (1) 1
factor-receptor (1) 1
flt3 mutations (1) 1
ftir (1) 1
gastric cancer (1) 1
gastric mucosa - pathology (1) 1
genes (1) 1
genetic research (1) 1
germany (1) 1
global positioning system (1) 1
gold (1) 1
ground-based gps (1) 1
health aspects (1) 1
helicobacter infections (1) 1
helicobacter infections - microbiology (1) 1
helicobacter infections - pathology (1) 1
helicobacter pylori (1) 1
hematology, oncology and palliative medicine (1) 1
hematopoietic stem cell transplantation (1) 1
hepatocyte growth factor - metabolism (1) 1
hepatocyte growth-factor (1) 1
hot spots (1) 1
human adipose-tissue (1) 1
human bone-marrow (1) 1
hypertension (1) 1
impact (1) 1
induced pluripotent stem cell (1) 1
induced pluripotent stem cells - cytology (1) 1
induced pluripotent stem cells - metabolism (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 16, pp. 1691 - 1699
Summary Background Preclinical data and results from non-randomised trials suggest that the multikinase inhibitor sorafenib might be an effective drug for the... 
Hematology, Oncology and Palliative Medicine | AML | ONCOLOGY | ACUTE MYELOGENOUS LEUKEMIA | BONE-MARROW | CLASSIFICATION | FLT3 MUTATIONS | CYTARABINE | STEM-CELL TRANSPLANTATION | COMBINATION | ELDERLY-PATIENTS | CHEMOTHERAPY | Niacinamide - analogs & derivatives | Recurrence | Age Factors | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Protein Kinase Inhibitors - adverse effects | Transplantation, Homologous | Neoadjuvant Therapy - mortality | Time Factors | Phenylurea Compounds - adverse effects | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Chemotherapy, Adjuvant | Daunorubicin - therapeutic use | Double-Blind Method | Risk Factors | Kaplan-Meier Estimate | Niacinamide - adverse effects | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Treatment Outcome | Disease Progression | Leukemia, Myeloid, Acute - mortality | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Leukemia, Myeloid, Acute - diagnosis | Antibiotics, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - adverse effects | Protein Kinase Inhibitors - therapeutic use | Germany | Antimitotic agents | Clinical trials | Chemotherapy | Antineoplastic agents | Standards | Cancer
Journal Article
Atmospheric Chemistry and Physics, ISSN 1680-7316, 2012, Volume 12, Issue 22, pp. 10925 - 10943
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.